Phytochemicals and Their Possible Mechanisms in Managing COVID-19 and Diabetes

被引:4
作者
Sandoval-Gallegos, Eli Mireya [1 ]
Ramirez-Moreno, Esther [1 ]
Vargas-Mendoza, Nancy [2 ]
Arias-Rico, Jose [3 ]
Estrada-Luna, Diego [3 ]
Cuevas-Cancino, Jose Javier [3 ]
Jimenez-Sanchez, Reyna Cristina [3 ]
Flores-Chavez, Olga Rocio [3 ]
Baltazar-Tellez, Rosa Maria [3 ]
Morales-Gonzalez, Jose A. [2 ]
机构
[1] Univ Autonoma Estado Hidalgo, Area Acad Nutr, Ctr Invest Interdisciplinario, Inst Ciencias Salud, Circuito Ex Hacienda Concepc S-N, Carretera Pachuca 42160, San Agustin Tla, Mexico
[2] Inst Politecn Nacl Mexico Escuela Super Med, Lab Med Conservac Escuela Super Med, Plan San Luis Diaz Miron, Col Casco Santo Tomas,Alcaldia Miguel Hidalgo, Mexico City 11340, DF, Mexico
[3] Univ Autonoma Estado Hidalgo, Area Acad Enfermeria, Inst Ciencias Salud, Circuito Ex Hacienda Concepc S-N, Carretera Pachuca 42160, San Agustin Tla, Mexico
来源
APPLIED SCIENCES-BASEL | 2021年 / 11卷 / 17期
关键词
diabetes; SARS-CoV-2; COVID-19; curcumin; silymarin; sulforaphane; SILYMARIN; CURCUMIN; SARS-COV-2; BIOAVAILABILITY; SULFORAPHANE; CORONAVIRUS; CONSUMPTION; PREVENTION; DISORDER; NRF2;
D O I
10.3390/app11178163
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
For the writing of this manuscript, we searched information published from 2000 to 2021, through PubMed, Web of Science, Springer, and Science Direct. Focusing on the effects related to respiratory diseases, in addition to possible direct effects towards SARS-CoV-2, coupled with diabetes. Diabetes is a metabolic disease that is characterized by affecting the function of glucose, in addition to insulin insufficiency. This leads to patients with such pathologies as being at greater risk for developing multiple complications and increase exposure to viruses infections. This is the case of severe acute respiratory disease coronavirus 19 (SARS-CoV-2), which gave rise to coronavirus disease 2019 (COVID-19), declared an international public health emergency in March of 2020 Currently, several strategies have been applied in order to prevent the majority of the consequences of COVID-19, especially in patients with chronic diseases such as diabetes. Among the possible treatment options, we found that the use of phytochemical compounds has exhibited beneficial effects for the prevention and inhibition of infection by SARS-CoV-2, as well as for the improvement of the manifestations of diabetes.
引用
收藏
页数:13
相关论文
共 50 条
[21]   The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms [J].
Sourav Roy ;
Tanoy Mazumder ;
Sujan Banik .
SN Comprehensive Clinical Medicine, 2020, 2 (8) :1077-1082
[22]   COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19? [J].
Al-kuraishy, Hayder Mutter ;
Al-Gareeb, Ali Ismail ;
Mostafa-Hedeab, Gomaa ;
Dubey, Rupal ;
Prabhakar, Pranav Kumar ;
Batiha, Gaber El-Saber .
CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (04) :494-506
[23]   Diabetes, infection risk and COVID-19 [J].
Erener, Suheda .
MOLECULAR METABOLISM, 2020, 39
[24]   COVID-19 and diabetes: A bidirectional relationship [J].
Lima-Martinez, Marcos M. ;
Boada, Carlos Carrera ;
Madera-Silva, Marialaura D. ;
Marin, Waleskha ;
Contreras, Miguel .
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (03) :151-157
[25]   The Severity of COVID-19 in Diabetes Patients [J].
Danao, Kishor ;
Rokde, Vijayshri ;
Bali, Nikhil ;
Mahajan, Ujwala .
CURRENT DIABETES REVIEWS, 2023, 19 (05)
[26]   COVID-19 and diabetes: Is there enough evidence? [J].
Tadic, Marijana ;
Cuspidi, Cesare ;
Sala, Carla .
JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (06) :943-948
[27]   The essentials of diabetes prevention and management during COVID-19 pandemic [J].
Ayenigbara, Israel Oluwasegun .
CLINICAL DIABETOLOGY, 2021, 10 (06) :429-437
[28]   Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin [J].
Mozafari, Negin ;
Azadi, Soha ;
Mehdi-Alamdarlou, Sanaz ;
Ashrafi, Hajar ;
Azadi, Amir .
MEDICAL HYPOTHESES, 2020, 143
[29]   Possible mechanisms of cholesterol elevation aggravating COVID-19 [J].
Tang, Yan ;
Hu, Longtai ;
Liu, Yi ;
Zhou, Bangyi ;
Qin, Xiaohuan ;
Ye, Jujian ;
Shen, Maoze ;
Wu, Zhijian ;
Zhang, Peidong .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (15) :3533-3543
[30]   Atrial fibrillation in COVID-19: A review of possible mechanisms [J].
Stone, Elijah ;
Kiat, Hosen ;
McLachlan, Craig S. .
FASEB JOURNAL, 2020, 34 (09) :11347-11354